80 likes | 102 Views
The global sanger's sequencing service market was valued at $192 million in 2013, and is projected to reach $1,085 million by 2025, at a CAGR of 14.2% from 2018 to 2025.
E N D
Sangers SequencingService Market Global Opportunity Analysis and Industry Forecast, 2013-2025
Introduction • The global sanger's sequencing service market was valued at $192 million in 2013, and is projected to reach $1,085 million by 2025, at a CAGR of 14.2% from 2018 to 2025. The growth of the market is driven by factors such as increase in the usage and applications of sanger's sequencing, especially in oncology research, diagnostics, reproductive health, and others. Furthermore, the market for sanger's sequencing services has witnessed tremendous growth in the recent years, due to upsurge in demand for this technique in genomics, transcriptomics, and other life science-related research areas.
Market Growth Factors • Technological advancements in sequencing procedures • Advantages associated with Sanger’s sequencing • Increase in genome mapping programs
Table of Content Chapter: 1: Introduction Chapter: 2: Executive Summary Chapter: 3: Market Overview Chapter: 4: Global And Regional Sanger's Sequencing Service Market Share Analysis Chapter: 5: Global Sanger's Sequencing Service Market, By Application Chapter: 6: Global Sanger's Sequencing Service Market, By End User Chapter: 7: Global Sanger's Sequencing Service Market, By Region Chapter: 8: Company Profiles
Analyst Review Sanger's sequencing has enhanced diverse fields of life sciences through research innovation and development. Biomarker discovery, oncology studies, drug development, personalized genomics, and reproductive health are some of the widely known applications of this technique. Similarly, it has contributed significantly in agricultural & animal and forensic research. Sanger's sequencing services are anticipated to witness high adoption with increase in distinct applications and interventions, such as biomarker discovery, personalized medicine, and others. The market has gained momentum in the R&D sector, owing to increase in genome mapping projects globally. In addition, rise in awareness about Sanger's sequencing and its advantages drives the market.
Market Segments By Application By End User Academic & Government Research Institutes Pharmaceutical Companies Biotechnology Companies Hospitals & Clinics • Diagnostics • Biomarkers & Cancer • Reproductive Health • Personalized Medicine • Forensics • Others
Company Profiles • CeMIASA • FasterisSA • GENEWIZ, Inc. • GenHunterCorporation • Genscript Biotech Corporation • LGC Science Group Holdings Limited
ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/sangers-sequencing-service-market Follow UsOn